Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Endokrynologia Polska
MENU
Shortcuts Submit an article Author Guidelines Polish Society of Endocrinology Reviewers 2023 Redeem voucher

open access

Vol 68, No 1 (2017)
Review paper
Submitted: 2016-03-01
Accepted: 2016-05-24
Published online: 2017-03-01
View PDF Download PDF file
Get Citation

Thyroid dysfunction in obese and overweight children

Ewelina Witkowska-Sędek, Anna Kucharska, Małgorzata Rumińska, Beata Pyrżak
DOI: 10.5603/EP.2017.0007
·
Pubmed: 28255980
·
Endokrynol Pol 2017;68(1):54-60.

open access

Vol 68, No 1 (2017)
Review Article
Submitted: 2016-03-01
Accepted: 2016-05-24
Published online: 2017-03-01

Abstract

Obesity and thyroid function are closely related. Thyroid hormones are involved in the regulation of metabolism, thermogenesis, food intake, and fat oxidation. In obese children the most frequent hormonal abnormalities are slight hyperthyrotropinaemia and moderate increases in total T3 and/or fT3 concentrations. Those abnormalities are usually considered a cause of obesity, but according to recent studies, they should actually be considered an adaptation process aimed at increasing resting energy expenditure and total energy expenditure. Those abnormalities do not require any treatment and normalise after substantial weight loss. The mechanisms of those changes are dependent on leptin, thyroid hormone resistance, and mitochondrial dysfunction. The present paper describes the abovementioned mechanisms based on the latest research. We also present a review of some recent original studies evaluating thyroid function in overweight and obese children, including thyroid ultrasound. A thyroid ultrasound scan in obese children frequently shows increased thyroid volume, which correlates with moderately increased TSH levels and a hypoechoic pattern typical of autoimmune thyroiditis, but without antithyroid autoantibodies. Alterations of thyroid function in overweight and obese patients cause an increase in energy expenditure, which facilitates weight loss and prevents further weight gain. Therefore, normalisation of TSH and fT3 after weight loss could explain difficulties in maintaining reduced weight. (Endokrynol Pol 2017; 68 (1): 54–60)

Abstract

Obesity and thyroid function are closely related. Thyroid hormones are involved in the regulation of metabolism, thermogenesis, food intake, and fat oxidation. In obese children the most frequent hormonal abnormalities are slight hyperthyrotropinaemia and moderate increases in total T3 and/or fT3 concentrations. Those abnormalities are usually considered a cause of obesity, but according to recent studies, they should actually be considered an adaptation process aimed at increasing resting energy expenditure and total energy expenditure. Those abnormalities do not require any treatment and normalise after substantial weight loss. The mechanisms of those changes are dependent on leptin, thyroid hormone resistance, and mitochondrial dysfunction. The present paper describes the abovementioned mechanisms based on the latest research. We also present a review of some recent original studies evaluating thyroid function in overweight and obese children, including thyroid ultrasound. A thyroid ultrasound scan in obese children frequently shows increased thyroid volume, which correlates with moderately increased TSH levels and a hypoechoic pattern typical of autoimmune thyroiditis, but without antithyroid autoantibodies. Alterations of thyroid function in overweight and obese patients cause an increase in energy expenditure, which facilitates weight loss and prevents further weight gain. Therefore, normalisation of TSH and fT3 after weight loss could explain difficulties in maintaining reduced weight. (Endokrynol Pol 2017; 68 (1): 54–60)

Full Text:

View PDF Download PDF file
Get Citation

Keywords

thyroid function; obesity; children

About this article
Title

Thyroid dysfunction in obese and overweight children

Journal

Endokrynologia Polska

Issue

Vol 68, No 1 (2017)

Article type

Review paper

Pages

54-60

Published online

2017-03-01

Page views

6272

Article views/downloads

5233

DOI

10.5603/EP.2017.0007

Pubmed

28255980

Bibliographic record

Endokrynol Pol 2017;68(1):54-60.

Keywords

thyroid function
obesity
children

Authors

Ewelina Witkowska-Sędek
Anna Kucharska
Małgorzata Rumińska
Beata Pyrżak

References (75)
  1. WHO, Fact sheet N°311, Updated January 2015. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
  2. Haslam D, James W. Obesity. The Lancet. 2005; 366(9492): 1197–1209.
    CrossRef
  3. Pujanek M, Bronisz A, Małecki P, et al. Pathomechanisms of the development of obesity in some endocrinopathies - an overview. Endokrynol Pol. 2013; 64(2): 150–155.
    PubMed
  4. Rotondi M, Leporati P, La Manna A, et al. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? Eur J Endocrinol. 2009; 160(3): 403–408.
    CrossRefPubMed
  5. Longhi S, Radetti G. Thyroid function and obesity. J Clin Res Pediatr Endocrinol. 2013; 5 Suppl 1: 40–44.
    CrossRefPubMed
  6. Pacifico L, Anania C, Ferraro F, et al. Thyroid function in childhood obesity and metabolic comorbidity. Clin Chim Acta. 2012; 413(3-4): 396–405.
    CrossRefPubMed
  7. Marras V, Casini MR, Pilia S, et al. Thyroid function in obese children and adolescents. Horm Res Paediatr. 2010; 73(3): 193–197.
    CrossRefPubMed
  8. Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol. 2010; 316(2): 165–171.
    CrossRefPubMed
  9. Nathan BM, Moran A. Metabolic complications of obesity in childhood and adolescence: more than just diabetes. Curr Opin Endocrinol Diabetes Obes. 2008; 15(1): 21–29.
    CrossRefPubMed
  10. Reinehr T, Isa A, de Sousa G, et al. Thyroid hormones and their relation to weight status. Horm Res. 2008; 70(1): 51–57.
    CrossRefPubMed
  11. Rotondi M, Magri F, Chiovato L. Thyroid and obesity: not a one-way interaction. J Clin Endocrinol Metab. 2011; 96(2): 344–346.
    CrossRefPubMed
  12. Biondi B. Thyroid and obesity: an intriguing relationship. J Clin Endocrinol Metab. 2010; 95(8): 3614–3617.
    CrossRefPubMed
  13. Laurberg P, Knudsen N, Andersen S, et al. Thyroid function and obesity. Eur Thyroid J. 2012; 1(3): 159–167.
    CrossRefPubMed
  14. Pearce EN. Thyroid hormone and obesity. Curr Opin Endocrinol Diabetes Obes. 2012; 19(5): 408–413.
    CrossRefPubMed
  15. Duntas LH, Biondi B. The interconnections between obesity, thyroid function, and autoimmunity: the multifold role of leptin. Thyroid. 2013; 23(6): 646–653.
    CrossRefPubMed
  16. Sorisky A, Bell A, Gagnon A. TSH receptor in adipose cells. Horm Metab Res. 2000; 32(11-12): 468–474.
    CrossRefPubMed
  17. Valyasevi RW, Harteneck DA, Dutton CM, et al. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab. 2002; 87(5): 2352–2358.
    CrossRefPubMed
  18. Michalaki MA, Vagenakis AG, Leonardou AS, et al. Thyroid function in humans with morbid obesity. Thyroid. 2006; 16(1): 73–78.
    CrossRefPubMed
  19. Bastemir M, Akin F, Alkis E, et al. Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss Med Wkly. 2007; 137(29-30): 431–434.
    CrossRefPubMed
  20. De Pergola G, Ciampolillo A, Paolotti S, et al. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol (Oxf). 2007; 67(2): 265–269.
    CrossRefPubMed
  21. Knudsen N, Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab. 2005; 90(7): 4019–4024.
    CrossRefPubMed
  22. De Pergola G, Ciampolillo A, Alò D, et al. Free triiodothyronine is associated with smoking habit, independently of obesity, body fat distribution, insulin, and metabolic parameters. J Endocrinol Invest. 2010; 33(11): 815–818.
    CrossRefPubMed
  23. Santini F, Marzullo P, Rotondi M, et al. Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. Eur J Endocrinol. 2014; 171(4): R137–R152.
    CrossRefPubMed
  24. Reinehr T, Hinney A, de Sousa G, et al. Definable somatic disorders in overweight children and adolescents. J Pediatr. 2007; 150(6): 618–22, 622.e1.
    CrossRefPubMed
  25. Stichel H, l'Allemand D, Grüters A. Thyroid function and obesity in children and adolescents. Horm Res. 2000; 54(1): 14–19.
    CrossRefPubMed
  26. Bhowmick SK, Dasari G, Levens KL, et al. The prevalence of elevated serum thyroid-stimulating hormone in childhood/adolescent obesity and of autoimmune thyroid diseases in a subgroup. J Natl Med Assoc. 2007; 99(7): 773–776.
    PubMed
  27. Reinehr T, Andler W. Thyroid hormones before and after weight loss in obesity. Arch Dis Child. 2002; 87(4): 320–323.
    PubMed
  28. Reinehr T, de Sousa G, Andler W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab. 2006; 91(8): 3088–3091.
    CrossRefPubMed
  29. Kok P, Roelfsema F, Langendonk JG, et al. High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab. 2005; 90(8): 4659–4663.
    CrossRefPubMed
  30. Feldt-Rasmussen U. Thyroid and leptin. Thyroid. 2007; 17(5): 413–419.
    CrossRefPubMed
  31. Zimmermann-Belsing T, Brabant G, Holst JJ, et al. Circulating leptin and thyroid dysfunction. Eur J Endocrinol. 2003; 149(4): 257–271.
    PubMed
  32. Iacobellis G, Ribaudo MC, Zappaterreno A, et al. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf). 2005; 62(4): 487–491.
    CrossRefPubMed
  33. Aeberli I, Jung A, Murer SB, et al. During rapid weight loss in obese children, reductions in TSH predict improvements in insulin sensitivity independent of changes in body weight or fat. J Clin Endocrinol Metab. 2010; 95(12): 5412–5418.
    CrossRefPubMed
  34. Gertig AM, Niechciał E, Skowrońska B. Thyroid axis alterations in childhood obesity. Pediatr Endocrinol Diabetes Metab. 2012; 18(3): 116–119.
    PubMed
  35. Ribeiro AC, Ceccarini G, Dupré C, et al. Contrasting effects of leptin on food anticipatory and total locomotor activity. PLoS One. 2011; 6(8): e23364.
    CrossRefPubMed
  36. Myers MG, Leibel RL, Seeley RJ, et al. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab. 2010; 21(11): 643–651.
    CrossRefPubMed
  37. López M, Alvarez CV, Nogueiras R, et al. Energy balance regulation by thyroid hormones at central level. Trends Mol Med. 2013; 19(7): 418–427.
    CrossRefPubMed
  38. Górska E, Wąsik M. Experimental immunology Differences in the expression of leptin receptors on bone marrow and peripheral blood cells. Central European Journal of Immunology. 2012; 4: 332–337.
    CrossRef
  39. Nillni EA. Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs. Front Neuroendocrinol. 2010; 31(2): 134–156.
    CrossRefPubMed
  40. Fekete C, Kelly J, Mihály E, et al. Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis. Endocrinology. 2001; 142(6): 2606–2613.
    CrossRefPubMed
  41. Fekete C, Légrádi G, Mihály E, et al. alpha-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J Neurosci. 2000; 20(4): 1550–1558.
    PubMed
  42. Kim MS, Small CJ, Stanley SA, et al. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest. 2000; 105(7): 1005–1011.
    CrossRefPubMed
  43. Rapa A, Monzani A, Moia S, et al. Subclinical hypothyroidism in children and adolescents: a wide range of clinical, biochemical, and genetic factors involved. J Clin Endocrinol Metab. 2009; 94(7): 2414–2420.
    CrossRefPubMed
  44. Santini F, Galli G, Maffei M, et al. Acute exogenous TSH administration stimulates leptin secretion in vivo. Eur J Endocrinol. 2010; 163(1): 63–67.
    CrossRefPubMed
  45. Menendez C, Baldelli R, Camiña JP, et al. TSH stimulates leptin secretion by a direct effect on adipocytes. J Endocrinol. 2003; 176(1): 7–12.
    PubMed
  46. Clément K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998; 392(6674): 398–401.
    CrossRefPubMed
  47. Légrádi G, Emerson CH, Ahima RS, et al. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology. 1997; 138(6): 2569–2576.
    CrossRefPubMed
  48. Coppola A, Meli R, Diano S. Inverse shift in circulating corticosterone and leptin levels elevates hypothalamic deiodinase type 2 in fasted rats. Endocrinology. 2005; 146(6): 2827–2833.
    CrossRefPubMed
  49. Burman KD, Latham KR, Djuh YY, et al. Solubilized nuclear thyroid hormone receptors in circulating human mononuclear cells. J Clin Endocrinol Metab. 1980; 51(1): 106–116.
    CrossRefPubMed
  50. Shimura H, Miyazaki A, Haraguchi K, et al. Analysis of differentiation-induced expression mechanisms of thyrotropin receptor gene in adipocytes. Mol Endocrinol. 1998; 12(10): 1473–1486.
    CrossRefPubMed
  51. Endo T, Ohno M, Kotani S, et al. Thyrotropin receptor in non-thyroid tissues. Biochem Biophys Res Commun. 1993; 190(3): 774–779.
    CrossRefPubMed
  52. Nannipieri M, Cecchetti F, Anselmino M, et al. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int J Obes (Lond). 2009; 33(9): 1001–1006.
    CrossRefPubMed
  53. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995; 332(20): 1351–1362.
    CrossRefPubMed
  54. Ajjan RA, Watson PF, Findlay C, et al. The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity. J Endocrinol. 1998; 158(3): 351–358.
    PubMed
  55. Pekary AE, Hershman JM. Tumor necrosis factor, ceramide, transforming growth factor-beta1, and aging reduce Na+/I- symporter messenger ribonucleic acid levels in FRTL-5 cells. Endocrinology. 1998; 139(2): 703–712.
    CrossRefPubMed
  56. Antunes TT, Gagnon A, Chen B, et al. Interleukin-6 release from human abdominal adipose cells is regulated by thyroid-stimulating hormone: effect of adipocyte differentiation and anatomic depot. Am J Physiol Endocrinol Metab. 2006; 290(6): E1140–E1144.
    CrossRefPubMed
  57. Reinehr T. Thyroid function in the nutritionally obese child and adolescent. Curr Opin Pediatr. 2011; 23(4): 415–420.
    CrossRefPubMed
  58. Shalitin S, Yackobovitch-Gavan M, Phillip M. Prevalence of thyroid dysfunction in obese children and adolescents before and after weight reduction and its relation to other metabolic parameters. Horm Res. 2009; 71(3): 155–161.
    CrossRefPubMed
  59. Onur S, Haas V, Bosy-Westphal A, et al. L-tri-iodothyronine is a major determinant of resting energy expenditure in underweight patients with anorexia nervosa and during weight gain. Eur J Endocrinol. 2005; 152(2): 179–184.
    CrossRefPubMed
  60. Grandone A, Santoro N, Coppola F, et al. Thyroid function derangement and childhood obesity: an Italian experience. BMC Endocr Disord. 2010; 10: 8.
    CrossRefPubMed
  61. Ghergherehchi R, Hazhir N. Thyroid hormonal status among children with obesity. Ther Adv Endocrinol Metab. 2015; 6(2): 51–55.
    CrossRefPubMed
  62. Lomenick JP, El-Sayyid M, Smith WJ. Effect of levo-thyroxine treatment on weight and body mass index in children with acquired hypothyroidism. J Pediatr. 2008; 152(1): 96–100.
    CrossRefPubMed
  63. Kaptein EM, Beale E, Chan LS. Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metab. 2009; 94(10): 3663–3675.
    CrossRefPubMed
  64. Matusik P, Gawlik A, Januszek-Trzciakowska A, et al. Isolated Subclinical Hyperthyrotropinemia in Obese Children: Does Levothyroxine (LT4) Improve Weight Reduction during Combined Behavioral Therapy? Int J Endocrinol. 2015; 2015: 792509.
    CrossRefPubMed
  65. Lazarus J, Brown RS, Daumerie C, et al. 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014; 3(2): 76–94.
    CrossRefPubMed
  66. Karmisholt J, Andersen S, Laurberg P. Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy. Eur J Endocrinol. 2011; 164(3): 317–323.
    CrossRefPubMed
  67. Gietka-Czernel M, Jastrzębska H. Norma TSH – czy należy ją zmienić? Endokrynol Pol. 2007; 58: 454–460.
  68. Zöphel K, Wunderlich G, Kotzerke J. Should we really determine a reference population for the definition of thyroid-stimulating hormone reference interval? Clin Chem. 2006; 52(2): 329–330.
    CrossRefPubMed
  69. Radetti G, Kleon W, Buzi F, et al. Thyroid function and structure are affected in childhood obesity. J Clin Endocrinol Metab. 2008; 93(12): 4749–4754.
    CrossRefPubMed
  70. Szybiński Z, Trofimiuk-Müldner M, Buziak-Bereza M, et al. Reference values for thyroid volume established by ultrasound in Polish schoolchildren. Endokrynol Pol. 2012; 63(2): 104–109.
    PubMed
  71. Rotondi M, Cappelli C, Leporati P, et al. A hypoechoic pattern of the thyroid at ultrasound does not indicate autoimmune thyroid diseases in patients with morbid obesity. Eur J Endocrinol. 2010; 163(1): 105–109.
    CrossRefPubMed
  72. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004; 89(6): 2548–2556.
    CrossRefPubMed
  73. Olszanecka-Glinianowicz M, Chudek J, Szromek A, et al. Changes of systemic microinflammation after weight loss and regain - a five-year follow up study. Endokrynol Pol. 2012; 63(6): 432–438.
    PubMed
  74. Garanty-Bogacka B, Syrenicz M, Goral J, et al. Changes in inflammatory biomarkers after successful lifestyle intervention in obese children. Endokrynol Pol. 2011; 62(6): 499–505.
    PubMed
  75. Radetti G, Longhi S, Baiocchi M, et al. Changes in lifestyle improve body composition, thyroid function, and structure in obese children. J Endocrinol Invest. 2012; 35(3): 281–285.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl